You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 紅日藥業午後直線拉漲逾4% 公司血必淨注射液列入新冠肺炎推薦用藥
格隆匯 02-20 13:21
格隆匯2月20日丨紅日藥業(300026.SZ)午後直線拉昇,現報4.79元,漲4.13%,暫成交4.9億元,最新總市值144億元。紅日藥業今日午間發公告稱,公司產品血必淨注射液列入《新型冠狀病毒肺炎診療方案(試行第六版)》推薦用藥。紅日藥業昨日在互動平台亦表示,公司產品血必淨注射液用於新型肺炎治療的定點醫院已超過1000家,目前使用範圍仍在進一步擴大,同時臨牀醫生反饋有確切療效。其他的數據目前還在進一步統計中。預計將對血必淨注射液產品的市場推廣和銷售產生積極影響,但對公司經營業績的影響暫無法估計。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account